Dakshidin Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DKSC research report →
Price Chart
About the company
Dakshidin Corporation, Inc. , through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products.
- CEO
- Christopher Robin Haigh
- IPO
- 2009
- HQ
- Miami, FL, US
Get TickerSpark's AI analysis on DKSC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.33M
- P/E
- -34.36
- PEG
- -0.34
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -34.36
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-41,330
- Net Income
- $-41,330+0.0%
- EPS
- $0.00+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -0.42
- RSI (14)
- 39
- Avg Volume
- 510.03K
No earnings-call transcripts are available for DKSC yet.
- Free Float
- 0.0%
- Shares Outstanding
- 4.43B
- Float Shares
- 0
Our DKSC coverage
Recent articles, reports, and earnings notes.
No research on DKSC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DKSC report →Dakshidin Corporation Marks Strategic Milestone with Stenergy LLC's IP Acquisition and COO Appointment
newsfilecorp.com · Oct 31
Whitechapel Announces Its Webinar Series - “Webinars for Living”
accesswire.com · Sep 14
Dakshidin Corporation (OTC: DKSC) Relaunches Updated Whitechapelholdingsusa.com & Laughingfrogs.com Websites
accesswire.com · Jul 13
Dakshidin CEO Joins GenBio CEO on Podcast to Discuss Entering 191 Billion Dollar Anti-Inflammatory Market, Their Strategic Partnership and Research Potential
accesswire.com · May 20
Dakshidin Corporation Signs Business Development Deal With Cicero Media Group
accesswire.com · Apr 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.